The appointments reflect EO Care’s leadership at a defining moment for the industry—marked by accelerating clinical validation, expanding reimbursement pathways, and growing demand from providers and ...

Cardiovascular disease is the leading cause of death in North Carolina, and effective management of the condition is essential to improving residents’ quality of life.

Drug-related provisions of a landmark Biden-era law were tied to a decline in cost-related medication nonadherence among ...

At the scientific symposium "A Revolution with Biosimilars," organized by the Vietnam Cancer Association and Pfizer Vietnam on March 6-7, 2026, in Hanoi and Ho Chi Minh City, experts discussed ...

Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide — brand name Revlimid — to treat it. She has not been able to fill that prescription in more than two ...

Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician ...

Modeling at 2023 net pricing estimated semaglutide would avert >358,000 cardiovascular events/deaths, saving ~$15B in cardiovascular care plus ~$8B in other care, but adding ~$344B lifetime drug spend ...

According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...

Please provide your email address to receive an email when new articles are posted on . Use of vaginal estrogen therapy does not affect recurrence risk for women previously diagnosed with endometrial ...

Next-generation chief pharmacy officer roles expand to enterprise strategy, financial leadership, and AI integration in health systems.

The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, according to an industry press release. The implantable device (Portal ...

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical ...